Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9734-9743
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9734
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9734
Table 1 Characteristics of patients included in the study
| Patients (n = 56) | Age (yr) (mean ± SD) | Male/female | Active/remission | |
| IBD (n = 48) | CD (n = 26) | 11 ± 3.08 | 16/10 | 23/3 |
| UC (n = 22) | 15 ± 3.88 | 12/10 | 15/7 | |
| CONTROLS (n = 8) | HC (n = 8) | 10 ± 4.60 | 4/4 | - |
- Citation: Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A. Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease. World J Gastroenterol 2016; 22(44): 9734-9743
- URL: https://www.wjgnet.com/1007-9327/full/v22/i44/9734.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i44.9734